China flexes regulatory muscle at rabies vax maker

A human rabies vaccine made by the Wuhan Institute of Biological Products in central China has been voluntarily recalled, according to China's drug regulator. High levels of an endotoxin were found in one batch, which had been packaged into nearly 11,000 doses.

The SFDA estimates that more than 8,000 of the doses had been used. No adverse events have been reported.

Last month, the SFDA fined a unit of Simcere Pharmaceutical $3.75 million for producing substandard human rabies vaccine. And the unit had to cover the cost of re-vaccination, another $3.4 million.

- here's the article

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.